Tryton Medical Enrolls First U.S. Patient in the EXTENDED ACCESS Registry

Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, announced that the first patient in the United States has been enrolled in the Extended Access Registry, a single arm study of its Tryton Side Branch Stent.



from Content Keyword RSS http://ift.tt/YwJGL5

via IFTTT